trial

A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug

NCTId NCT01592201
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Terminated
Enrollment 13 (actual)
Sponsored by Janssen, L.P. - Investigator Initiated Studies Program
Primary completion 2013-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Terminated
Enrollment
13 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2012-07
Primary completion
2013-06
Eligibility
ALL · 20 Years · 65 Years

Interventions & indications

Drugs
Paliperdidone ERAripiprazole

Sponsors

Janssen, L.P. - Investigator Initiated Studies ProgramLead Sponsor

Sites

0 total

Facts & assertions

4 sourced
Enrollment
13
Phase
PHASE4
Primary Completion Date
2013-06
Status
TERMINATED
relationships
The graph out of here
drug
Paliperdidone ER
drug
Aripiprazole
drug
lead_sponsor
Janssen, L.P. - Investigator Initiated Studies Program
company
indication
Schizophrenia
indication
Schizophrenia
indication
Mental Disorders
indication